首页> 美国卫生研究院文献>World Journal of Gastrointestinal Endoscopy >Repeat endoscopic submucosal dissection for recurrent gastric cancers after endoscopic submucosal dissection
【2h】

Repeat endoscopic submucosal dissection for recurrent gastric cancers after endoscopic submucosal dissection

机译:内镜黏膜下剥离后重复胃镜下黏膜下剥离术治疗复发性胃癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To clarify the safety and efficacy of repeat endoscopic submucosal dissection (re-ESD) for locally recurrent gastric cancers after ESD.METHODS: A retrospective evaluation was performed of the therapeutic efficacy, complications and follow-up results from ESD treatment for early gastric cancers in 521 consecutive patients with 616 lesions at St. Luke`s International Hospital between April 2004 and November 2012. In addition, tumor size, the size of resected specimens and the operation time were compared between re-ESD and initial ESD procedures. A flex knife was used as the primary surgical device and a hook knife was used in cases with severe fibrosis in the submucosal layer. Continuous variables were analyzed using the non-parametric Mann-Whitney U test and are expressed as medians (range). Categorical variables were analyzed using a Fisher’s exact test and are reported as proportions. Statistical significance was defined as a P-value less than 0.05.RESULTS: The number of cases in the re-ESD group and the initial ESD group were 5 and 611, respectively. The median time interval from the initial ESD to re-ESD was 14 (range, 4-44 mo). En bloc resection with free lateral and vertical margins was successfully performed in all re-ESD cases without any complications. No local or distant recurrence was observed during the median follow-up period of 48 (range, 11-56 mo). Tumor size was not significantly different between the re-ESD group and the initial ESD group (median 22 mm vs 11 mm, P = 0.09), although the size of resected specimens was significantly larger in the re-ESD group (median 47 mm vs 34 mm, P < 0.05). There was a non-significant increase observed in re-ESD operation time compared to initial ESD (median 202 min vs 67 min, respectively, P = 0.06).CONCLUSION: Despite the low patient number and short follow-up, the results suggest that re-ESD is a safe and effective endoscopic treatment for recurrent gastric cancer after ESD.
机译:目的:阐明重复内镜黏膜下剥离术(re-ESD)对ESD术后局部复发胃癌的安全性和有效性方法:回顾性评估ESD治疗早期胃癌的疗效,并发症和随访结果2004年4月至2012年11月间,在圣卢克国际医院连续521例患者接受了616例病变的癌症治疗。此外,比较了再次ESD和初始ESD程序的肿瘤大小,切除标本的大小和手术时间。弯曲刀用作主要手术器械,钩刀用于粘膜下层严重纤维化的情况。使用非参数Mann-Whitney U检验分析了连续变量,并表示为中位数(范围)。使用Fisher精确检验对分类变量进行了分析,并按比例报告。统计显着性定义为P值小于0.05。结果:再次ESD组和初始ESD组的病例数分别为5和611。从初始ESD到再次ESD的平均时间间隔为14(范围为4-44 mo)。在所有再次ESD病例中均成功进行了具有自由的侧向和垂直边缘的整块切除术,没有任何并发​​症。在中位随访期48(范围11-56 mo)内未观察到局部或远处复发。再ESD组和初始ESD组之间的肿瘤大小没有显着差异(中位22 mm vs 11 mm,P = 0.09),尽管再ESD组中切除的标本的大小明显更大(中位47 mm vs 34毫米,P <0.05)。与最初的ESD相比,再次ESD手术时间没有显着增加(分别为202分钟和67分钟,P = 0.06)。结论:尽管患者人数少且随访时间短,结果表明: re-ESD是ESD后复发性胃癌的一种安全有效的内窥镜治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号